Value of Prostate-Specific Antigen Kinetics in Patients with Low-Risk Prostate Cancer under Active Surveillance
- 16 June 2023
- journal article
- research article
- Published by S. Karger AG in Urologia Internationalis
- Vol. 107 (7) , 706-712
Abstract
Introduction: This study analyzes the value of PSA kinetics, PSA speed (vPSA), and PSA doubling time (PSAdt), in patients with low-risk prostate cancer who are in an active surveillance (AS) program. Methods: An observational, retrospective, and longitudinal study of a sample of 86 patients included in AS program between January 2014 and October 2021 was conducted. A review of their medical records was performed, and PSA kinetics were calculated, analyzing the causes of discontinuation of the AS program and its relationship with PSA kinetics. Results: The mean age was 63.39 years, and the median follow-up was 62.55 months. The mean PSA at diagnosis was 8.27 ng/mL. A median of PSAdt of 62.55 months and 1.3 ng/mL/year for vPSA was obtained. 35 patients left the program, with a higher percentage of patients leaving with a PSAdt less than 36 months (73.7 vs. 31.1%) and a vPSA greater than 2 ng/mL/year (68.2 vs. 31.3%). The probability of permanence and the time of permanence in AS were statistically significantly higher for those patients with favorable kinetic parameters. Conclusion: PSA kinetics is a parameter to take into account when making decisions to keep patients in an AS program.Keywords
This publication has 21 references indexed in Scilit:
- Outcomes of Active Surveillance for Clinically Localized Prostate Cancer in the Prospective, Multi-Institutional Canary PASS CohortJournal of Urology, 2016
- Programa de monitorización de la vigilancia activa en cáncer de próstata en España de la Sociedad Española de Urología; resultados preliminaresActas Urológicas Españolas, 2016
- Long-Term Follow-Up of a Large Active Surveillance Cohort of Patients With Prostate CancerJournal of Clinical Oncology, 2015
- Información obligatoria que debe conocer un paciente con cáncer de próstata candidato a vigilancia activaActas Urológicas Españolas, 2014
- Prostate‐specific antigen (PSA) kinetics in untreated, localized prostate cancer: PSA velocity vs PSA doubling timeBJU International, 2009
- Prostate-Specific Antigen Kinetics in Clinical Decision-Making During Active Surveillance for Early Prostate Cancer—A ReviewEuropean Urology, 2008
- Prospective Validation of Active Surveillance in Prostate Cancer: The PRIAS StudyEuropean Urology, 2007
- Variations in PSA doubling time in patients with prostate cancer on “watchful waiting”: Value of short-term PSADT determinationsUrology, 2004
- Natural History of Progression After PSA Elevation Following Radical ProstatectomyJAMA, 1999
- Longitudinal evaluation of prostate-specific antigen levels in men with and without prostate diseaseJAMA, 1992